| Literature DB >> 22863616 |
Baptiste N Jaeger1, Eric Vivier.
Abstract
Cells of the immune system have evolved various molecular mechanisms to sense their environment and react to alterations of self. NK cells are lymphocytes with effector and regulatory functions, which are remarkably adaptable to changes in self. In a study published in this issue of the JCI, Tarek and colleagues report the clinical benefits of manipulating NK cell adaptation to self in an innovative mAb-based therapy against neuroblastoma (NB). This novel therapeutic strategy should stimulate further research on NK cell therapies.Entities:
Year: 2012 PMID: 22863616 PMCID: PMC3428094 DOI: 10.1172/JCI63524
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808